おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
ChromaDex
company
About
ChromaDex is a provider of phytochemical standards, botanical materials, and research-grade materials for the natural products industry.
- 101 - 250
Details
- Last Funding Type
- Post-IPO Debt
- Last Funding Money Raised
- $5M
- Industries
- Biotechnology,Manufacturing,Nutraceutical,Product Research,Wellness
- Founded date
- Jan 1, 1999
- Number Of Employee
- 101 - 250
- Operating Status
- Active
ChromaDex is a global nutraceutical company. They leverage their complementary business units to discover, acquire, develop, and commercialize patented and proprietary ingredient technologies that address the dietary supplement, food, beverage, skin care, and pharmaceutical markets. They utilize in-house chemistry, regulatory, and safety consulting business units to develop commercially viable ingredients.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$5.22M
ChromaDex has raised a total of
$5.22M
in funding over 2 rounds. Their latest funding was raised on
Sep 30, 2014 from a Post-IPO Debt round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 30, 2014 | Post-IPO Debt | $5M | 1 | — | — | Detail |
| Jun 17, 2013 | Grant | $224.99K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
ChromaDex is funded by 2 investors.
National Science Foundation
and Hercules Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Hercules Capital
|
— | Post-IPO Debt |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
